PharmAthene cancels merger agreement with Theraclone

|By:, SA News Editor

PharmAthene (PIP +1.6%) terminates an agreement that called for a subsidiary to merge with Theraclone in an all-stock deal.

PIP will pay Theraclone a $1M termination fee. (PR)